UCB U.S. News

UCB's Global Corporate Website

Welcome to UCB in the United States

Archives

2024
- November
- October
- September
- August
- July
- June
- May
- April
- March
- February
- January
2023
- December
- November
- October
- September
- August
- July
- June
- May
- April
- March
- February
- January
2022
- December
- November
- October
- September
- August
- July
- June
- May
- April
- March
- February
- January
2021
- December
- November
- October
- September
- August
- July
- June
- May
- April
- March
- February
- January
2020
- December
- November
- October
- September
- August
- July
- June
- May
- April
- March
- February
- January
2019
- December
- November
- October
- September
- August
- July
- June
- May
- April
- March
- February
- January
2018
- December
- November
- October
- September
- August
- July
- June
- May
- April
- March
- February
- January

Jun

27 Fulfilling Our Ambition to Deliver an FDA-Approved Treatment for People Living with Generalized Myasthenia Gravis

Read More Share:

|

Jun

27 UCB announces U.S. FDA approval of RYSTIGGO® (rozanolixizumab-noli) for the treatment of adults with generalized myasthenia gravis

Read More Share:

|

Jun

14 How UCB Is Supporting the Mental Health of Patients and Caregivers

Read More Share:

|

Jun

14 Recognizing Ethical Leadership at UCB

Read More Share:

|

Jun

08 Employee Spotlight: Natasha Trujillo’s Passion for Advocacy

Read More Share:

|

Jun

02 Prioritizing Mental Health as a Caregiver to a Child With Dravet Syndrome

Read More Share:

|

Jun

01 Myasthenia Gravis Awareness Month is the Time to Understand More About the Lived Experiences of the Community

Read More Share:

|

Categories

Archives

Jun

27

Fulfilling Our Ambition to Deliver an FDA-Approved Treatment for People Living with Generalized Myasthenia Gravis

Jun

27

UCB announces U.S. FDA approval of RYSTIGGO® (rozanolixizumab-noli) for the treatment of adults with generalized myasthenia gravis

Jun

14

How UCB Is Supporting the Mental Health of Patients and Caregivers

Jun

14

Recognizing Ethical Leadership at UCB

Jun

08

Employee Spotlight: Natasha Trujillo’s Passion for Advocacy

Jun

02

Prioritizing Mental Health as a Caregiver to a Child With Dravet Syndrome

Jun

01

Myasthenia Gravis Awareness Month is the Time to Understand More About the Lived Experiences of the Community

Choose Country

UCB in the U.S.

Patients

Innovation

Sustainability

Newsroom

Contact

Categories

Archives

Jun

27

Fulfilling Our Ambition to Deliver an FDA-Approved Treatment for People Living with Generalized Myasthenia Gravis

Jun

27

UCB announces U.S. FDA approval of RYSTIGGO® (rozanolixizumab-noli) for the treatment of adults with generalized myasthenia gravis

Jun

14

How UCB Is Supporting the Mental Health of Patients and Caregivers

Jun

14

Recognizing Ethical Leadership at UCB

Jun

08

Employee Spotlight: Natasha Trujillo’s Passion for Advocacy

Jun

02

Prioritizing Mental Health as a Caregiver to a Child With Dravet Syndrome

Jun

01

Myasthenia Gravis Awareness Month is the Time to Understand More About the Lived Experiences of the Community

Choose Country

UCB in the U.S.

Patients

Innovation

UCB Worldwide

Sustainability

Newsroom

Contact